Integrative Research of Neuropharmacology and Informatics Pharmacology for Mental Disorder-Reference-Cited by-同舟云学术

Integrative Research of Neuropharmacology and Informatics Pharmacology for Mental Disorder

Published:2024-03-01 Issue:3 Volume:47 Page:556-561
ISSN:0918-6158
Container-title:Biological and Pharmaceutical Bulletin
language:en
Short-container-title:Biological & Pharmaceutical Bulletin

Author:

Nagayasu Kazuki¹

Affiliation:

1. Department of Molecular Pharmacology, Graduate School of Pharmaceutical Sciences, Kyoto University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpb/47/3/47_b23-00926/_pdf

Reference46 articles.

1. 1) Walker ER, McGee RE, Druss BG. Mortality in mental disorders and global disease burden implications a systematic review and meta-analysis. JAMA Psychiatry, 72, 334–341 (2015).

2. 2) Vos T, Allen C, Arora M, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study. Lancet, 388, 1545–1602 (2016).

3. 3) Brown WA, Rosdolsky M. The clinical discovery of imipramine. Am. J. Psychiatry, 172, 426–429 (2015).

4. 4) Hyttel J. Citalopram—pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity. Prog. Neuropsychopharmacol. Biol. Psychiatry, 6, 277–295 (1982).

5. 5) Ansseau M, von Frenckell R, Mertens C, de Wilde J, Botte L, Devoitille JM, Evrard JL, De Nayer A, Darimont P, Dejaiffe G, Mirel J, Meurice E, Parent M, Couzinier JP, Demarez JP, Serre C. Controlled comparison of two doses of milnacipran (F 2207) and amitriptyline in major depressive inpatients. Psychopharmacology (Berl.), 98, 163–168 (1989).